Brain Cancer section

Brain Cancer News and Features

Tumor-treating Fields Useful to Improve Glioblastoma Outcomes

Tumor-treating Fields Useful to Improve Glioblastoma Outcomes

Adverse event rates were similar in both trial groups, though patients treated with TTFields were much more likely to have mild to moderate skin toxicity.

History of Headache, Vomiting, Seizures Associated With Pediatric Brain Cancer

History of Headache, Vomiting, Seizures Associated With Pediatric Brain Cancer

Research pinpointed clinical factors, such as headache, that may be associated with pediatric brain neoplasms.

Drug Combination Does Not Extend Glioblastoma Survival

Drug Combination Does Not Extend Glioblastoma Survival

Lomustine plus bevacizumab may increase progression-free, but not overall, survival versus lomustine alone in progressive glioblastoma.

Invisible Burdens: The Complex Needs of Caregivers of Patients With Brain Cancer

Invisible Burdens: The Complex Needs of Caregivers of Patients With Brain Cancer

Caregivers of patients with malignant brain tumors often bear additional burdens in their role, as these patients often experience cognition-related adverse effects as well as the effects of their cancer and its treatment.

Zika Virus Preferentially Targets Glioblastoma Stem Cells

Zika Virus Preferentially Targets Glioblastoma Stem Cells

Researchers have determined that, relative to differentiated tumor progeny or normal neuronal cells, ZIKV preferentially infects and kills GSCs.

Brain Cancer Clinical Trials

Partial Response Achieved With Atezolizumab, Cobimetinib in Pretreated CRC

Safety and efficacy of atezolizumab with cobimetinib for heavily pretreated metastatic CRC was demonstrated in a phase 1b study that was presented at the 2018 Gastrointestinal Cancers Symposium.

Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib

Results of the double-blind phase 3 CELESTIAL study, presented at the 2018 Gastrointestinal Cancers Symposium, demonstrated efficacy of cabozantinib in patients with HCC who were previously treated with sorafenib.

Bridging the Gap in Genetic Cancer Research Data on Minority Populations

Investigators sought to determine why so few biospecimens were available for research from minority populations of women with breast cancer.

Tumor-treating Fields Useful to Improve Glioblastoma Outcomes

Adverse event rates were similar in both trial groups, though patients treated with TTFields were much more likely to have mild to moderate skin toxicity.

History of Headache, Vomiting, Seizures Associated With Pediatric Brain Cancer

Research pinpointed clinical factors, such as headache, that may be associated with pediatric brain neoplasms.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs